Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.jaad.2010.03.033 | DOI Listing |
Eur J Ophthalmol
November 2024
Department of Rheumatology, Albacete University Hospital, Albacete, Spain.
Cornea
January 2025
Service d'Ophtalmologie, Assistance Publique Hôpitaux de Paris (AP-HP), Université Paris-Saclay. Centre de Référence pour les maladies rares en ophtalmologie (OPHTARA), Le Kremlin-Bicêtre, France.
Int Med Case Rep J
July 2023
Oral Medicine Department, Faculty of Dentistry, Universitas Padjadjaran, Bandung, Indonesia.
Introduction: Pain management becomes important in the treatment of oral mucosal diseases since it can impair the quality of life. Photobiomodulation (PBM) as an alternative therapy, has potency in reducing pain through several mechanisms targeting peripheral nerves in the target tissue.
Purpose: To discuss the effectiveness of PBM in the management of four cases of oral mucosal diseases.
Microorganisms
May 2023
Laboratory of Clinical Immunology-Inflammation and Allergy LICIA, Faculty of Medicine and Pharmacy, Hassan II University, Casablanca 20250, Morocco.
Case Rep Ophthalmol
September 2022
aAnterior Segment Division, King Khaled Eye Specialist Hospital, Riyadh, Saudi Arabia.
The aim of this study was to report a severe case of mixed fungal and bacterial microbial keratitis following implantation of a self-retained cryopreserved amniotic membrane, PROKERA® SLIM (Bio-Tissue, Inc) in a patient with history of neurotrophic ulcer secondary to herpetic epithelial keratitis. Despite maximally tolerated topical and systemic therapy, the patient's eye continued to deteriorate and eventually required evisceration. PROKERA implantation might be associated with severe recalcitrant microbial keratitis.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!